+44-15180811362025: Volume 8, Issue 1
Perspective P.1-1
Addressing drug shortages: Strategies and challenges in pharmaceutical policy implementation.
Author(s):
John Woosley*
DOI: 10.35841/aajcrp.7.1.166
Perspective P.1-1
Analyzing the economic implications of orphan drug policies on pharmaceutical manufacturers and patients.
Author(s):
Peter Kelle*
DOI: 10.35841/aajcrp.7.1.167
Perspective P.1-1
Assessing the impact of generic drug substitution policies on patient outcomes: A comparative analysis.
Author(s):
Janey Johnson*
DOI: 10.35841/aajcrp.7.1.168
Perspective P.1-1
Evaluating the effectiveness of pharmaceutical price controls in enhancing access to essential medications.
Author(s):
Dana Goldman*
DOI: 10.35841/aajcrp.7.1.169
Perspective P.1-1
Exploring the influence of intellectual property rights on access to medicines: A global perspective.
Author(s):
Darius Lakdawalla*
DOI: 10.35841/aajcrp.7.1.170
Perspective P.1-1
Patient-centered approaches to pharmaceutical policy: Bridging the gap between healthcare providers and regulators.
Author(s):
Denis Horgan*
DOI: 10.35841/aajcrp.7.1.171
Perspective P.1-1
Pharmaceutical policy and drug safety: An in-depth examination of pharmacovigilance practices.
Author(s):
Matthew Epperson*
DOI: 10.35841/aajcrp.7.1.172
Perspective P.1-2
Pharmaceutical policy and the rise of biosimilars: Lessons learned and future directions.
Author(s):
Dinar Kale*
DOI: 10.35841/aajcrp.7.1.173
Perspective P.1-1
The impact of health insurance systems on medication adherence: A crossnational study.
Author(s):
Mahboub Bassam*
DOI: 10.35841/aajcrp.7.1.174
Perspective P.1-2
The role of health technology assessment in shaping pharmaceutical policy: Case studies from global health systems.
Author(s):
Lara Gautier*
DOI: 10.35841/aajcrp.7.1.175